3-(5-p-tolyl-1,3,4-oxadiazol-2-yl)aniline | 775302-21-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3-(5-p-tolyl-1,3,4-oxadiazol-2-yl)aniline
• 英文别名: 3-[5-(4-Methylphenyl)-1,3,4-oxadiazol-2-yl]aniline
• CAS: 775302-21-1
• 化学式: C₁₅H₁₃N₃O
• mdl: MFCD06760278
• 分子量: 251.288
• InChiKey: XHHUZHPBTZQUSD-UHFFFAOYSA-N

物化性质

• 沸点：
  462.6±55.0 °C(Predicted)
• 密度：
  1.209±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  19
• 可旋转键数：
  2
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  64.9
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT

反应信息

• 作为反应物：
  描述：

  3-(5-p-tolyl-1,3,4-oxadiazol-2-yl)aniline 在 sodium tetrahydroborate 、 potassium carbonate 、 三乙胺 作用下， 以 四氢呋喃 、 甲醇 、 丙酮 为溶剂， 反应 21.0h， 生成 5-hydroxy-N-(3-(5-p-tolyl-1,3,4-oxadiazol-2-yl)phenyl)pentanamide
  参考文献：
  名称：

  Synthesis and structure–activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles

  摘要：

  With the aim of discovering a novel class of non-phosphorus-based fructose-1,6-bisphosphatase (FBPase) inhibitors, a series of 2,5-diphenyl-1,3,4-oxadiazoles were synthesized based on the hit compound (1) resulting from a high-throughput screening (HTS). Structure-activity relationship (SAR) studies led to the identification of several compounds with comparable inhibitory activities to AMP, the natural allosteric inhibitor of FBPase. Notably, compound 22 and 27b, bearing a terminal carboxyl or 1H-tetrazole, demonstrated remarkable inhibition to gluconeogenesis (GNG). In addition, both inhibition and binding mode to the enzyme were investigated by enzymatic kinetics and in silico experiments for representative compounds 16 and 22.

  DOI：

  10.1016/j.ejmech.2014.06.011
• 作为产物：
  描述：

  N'-(4-methylbenzoyl)-3-nitrobenzohydrazide 在 氯化铵 、 锌 、 三氯氧磷 作用下， 以 四氢呋喃 、 甲醇 、 水 、 乙腈 为溶剂， 反应 12.0h， 生成 3-(5-p-tolyl-1,3,4-oxadiazol-2-yl)aniline
  参考文献：
  名称：

  Design, Synthesis and Biological Activity Evaluation of 2,5-Diphenyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Fructose-1,6-bisphosphatase

  摘要：

  Fructose-1,6-bisphosphatase (FBPase), an important gluconeogenic enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate. The effort to discover new FBPase inhibitors was carried out by high-throughput screening (HTS) of a library of 56,000 lead-like compounds, and a 2,5-diphenyl-1,3,4-oxadiazole (3a, IC50 = 15.45 mu M) which bearing no phosphate group was identified as a potential FBPase inhibitor for the first time. Structure-activity-relationship (SAR) research of a series of analogues obtained by modifying the substituent groups and replacing the 1,3,4-oxadiazole with several other heterocycles disclosed the key structure and substituent groups related to the binding with FBPase.

  DOI：

  10.3987/com-12-12565

文献信息

• 酰胺苯基-1,3,4-噁二唑类化合物及其制备方法 和应用
  申请人：华东师范大学

  公开号：CN104098526B

  公开（公告）日：2016-04-06

  本发明公开了一种如式(I)所示的酰胺苯基-1，3，4-噁二唑类化合物。本发明还公开了以氨基物II与取代脂肪酸III缩合得到酰胺苯基-1，3，4-噁二唑类化合物的制备方法。本发明还公开了酰胺苯基-1，3，4-噁二唑类化合物I在制备治疗II型糖尿病药物中的应用。本发明化合物为非AMP结构类型，能减小副作用风险，既在分子水平上明显抑制FBPase，又在细胞水平上显著抑制葡萄糖生成，细胞活性更好，成药性更佳。
• Design, Synthesis and Biological Activity Evaluation of 2,5-Diphenyl-1,3,4-oxadiazole Derivatives as Novel Inhibitors of Fructose-1,6-bisphosphatase
  作者：Fan Yang、Jia Li、Jing-Ya Li、Hai-Bing He、Yue-Yang Zhou、Ting Liu、Jie Tang、Xue-Ping Gong、Wen-Wei Qiu

  DOI：10.3987/com-12-12565

  日期：——

  Fructose-1,6-bisphosphatase (FBPase), an important gluconeogenic enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate. The effort to discover new FBPase inhibitors was carried out by high-throughput screening (HTS) of a library of 56,000 lead-like compounds, and a 2,5-diphenyl-1,3,4-oxadiazole (3a, IC50 = 15.45 mu M) which bearing no phosphate group was identified as a potential FBPase inhibitor for the first time. Structure-activity-relationship (SAR) research of a series of analogues obtained by modifying the substituent groups and replacing the 1,3,4-oxadiazole with several other heterocycles disclosed the key structure and substituent groups related to the binding with FBPase.
• Synthesis and structure–activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles
  作者：Ben-Ren Liao、Hai-Bing He、Ling-Ling Yang、Li-Xin Gao、Liang Chang、Jie Tang、Jing-Ya Li、Jia Li、Fan Yang

  DOI：10.1016/j.ejmech.2014.06.011

  日期：2014.8

  With the aim of discovering a novel class of non-phosphorus-based fructose-1,6-bisphosphatase (FBPase) inhibitors, a series of 2,5-diphenyl-1,3,4-oxadiazoles were synthesized based on the hit compound (1) resulting from a high-throughput screening (HTS). Structure-activity relationship (SAR) studies led to the identification of several compounds with comparable inhibitory activities to AMP, the natural allosteric inhibitor of FBPase. Notably, compound 22 and 27b, bearing a terminal carboxyl or 1H-tetrazole, demonstrated remarkable inhibition to gluconeogenesis (GNG). In addition, both inhibition and binding mode to the enzyme were investigated by enzymatic kinetics and in silico experiments for representative compounds 16 and 22.